Pfizer officially asks the FDA to authorize its COVID vaccine for kids aged 5-11

Enlarge this image


A healthcare worker prepares doses of the Pfizer-BioNTech Covid-19 vaccine at a mobile vaccination clinic at a high school in Los Angeles in August.





Jill Connelly/Bloomberg via Getty Images



hide caption



toggle caption


Jill Connelly/Bloomberg via Getty Images



Coronavirus Updates
Pfizer Submits Favorable Initial Data To The FDA On Kids’ COVID-19 Vaccine Trial

The submission is the latest development in the push to expand use of the vaccine to younger children, a process being closely watched by many anxious parents as the new school year gets underway.

The Pfizer-BioNTech vaccine has full FDA approval for people ages 16 and older, and those between the ages of 12 and 15 can get the shot under the current emergency use authorization.

Last month Pfizer and BioNTech submitted data to the FDA showing that their vaccine produced a «robust antibody response in kids from 5-11 and had «favorable safety outcomes.

• pfizer


• vaccine